Sarcolemmal α2 adrenoceptors (α2-AR), represented by α2A, α2B and α2C isoforms, can safeguard cardiac muscle under sympathoadrenergic surge by governing Ca handling and contractility of cardiomyocytes. Cardiomyocyte-specific targeting of α2-AR would provide cardiac muscle-delimited stress control and enhance the efficacy of cardiac malfunction treatments. However, little is known about the specific contribution of the α2-AR subtypes in modulating cardiomyocyte functions. Herein, we analyzed the expression profile of α2A, α2B and α2C subtypes in mouse ventricle and conducted electrophysiological antagonist assay evaluating the contribution of these isoforms to the suppression of L-type Ca current (). Patch-clamp electro-pharmacological studies revealed that the α2-agonist-induced suppression of involves mainly the α2C, to a lesser extent the α2B, and not the α2A isoforms. RT-qPCR evaluation revealed the presence of and (α2B and α2C isoform genes, respectively), but was unable to identify the expression of (α2A isoform gene) in the mouse left ventricle. Immunoblotting confirmed the presence only of the α2B and the α2C proteins in this tissue. The identified α2-AR isoform-linked regulation of in the mouse ventricle provides an important molecular substrate for the cardioprotective targeting.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072751PMC
http://dx.doi.org/10.3390/ijms22084135DOI Listing

Publication Analysis

Top Keywords

α2b α2c
16
suppression l-type
8
l-type current
8
α2a α2b
8
mouse ventricle
8
presence α2b
8
α2b
5
α2c
5
role α2-adrenoceptor
4
α2-adrenoceptor subtypes
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!